Several major infant formula brands, including a2 milk and Danone’s Aptamil, are successfully gaining market share despite a shrinking birth rate and tighter regulatory regime in China, their latest financial results have shown.
China’s infant formula giant Feihe says group profit was down 33.5 per cent in FY23, as the country struggles with raising its birth rate despite introducing a three-child policy three years ago.
It will mostly be the major domestic players and MNCs that will thrive in China’s infant formula market in the upcoming years, claim experts, citing a raft of reasons such as a more stringent regulatory environment, negative population growth, and an...
China infant formula firm Feihe said the popularity of its brands Astrobaby and Organic Zhenzhi have helped increase revenue for its infant milk portfolio by 41 per cent in FY2020, but its US dominated supplements business had plunged by 46 per cent.
